Phase I Study of Corticosteroid Treatment of Ill-Defined Choroidal Neovascularization in Age-Related Macular Degeneration
PHASE1CompletedINTERVENTIONAL
Enrollment
180
Participants
Timeline
Start Date
July 31, 1997
Study Completion Date
May 31, 2000
Conditions
Choroidal NeovascularizationMacular Degeneration
Interventions
DRUG
Corticosteroid
Trial Locations (1)
20892
National Eye Institute (NEI), Bethesda
All Listed Sponsors
lead
National Eye Institute (NEI)
NIH
NCT00001615 - Phase I Study of Corticosteroid Treatment of Ill-Defined Choroidal Neovascularization in Age-Related Macular Degeneration | Biotech Hunter | Biotech Hunter